Bruker Corporation
BRKR
$45.69
$0.711.58%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.36% | 2.08% | 6.10% | 10.36% | 14.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.36% | 2.08% | 6.10% | 10.36% | 14.84% |
| Cost of Revenue | 5.27% | 6.58% | 8.77% | 13.75% | 16.47% |
| Gross Profit | -4.57% | -2.42% | 3.42% | 7.03% | 13.24% |
| SG&A Expenses | 4.02% | 5.72% | 10.77% | 16.30% | 21.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 163.64% | 243.37% | -407.22% | 23.16% | 30.26% |
| Total Operating Expenses | 4.98% | 6.78% | 8.42% | 15.51% | 19.30% |
| Operating Income | -35.32% | -32.25% | -10.41% | -21.42% | -10.90% |
| Income Before Tax | -91.38% | -89.77% | -97.81% | -70.16% | -68.89% |
| Income Tax Expenses | -71.23% | -67.94% | -63.33% | -41.14% | -25.37% |
| Earnings from Continuing Operations | -111.96% | -107.29% | -107.75% | -78.69% | -80.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -320.00% | 57.14% | 575.00% | 650.00% | 166.67% |
| Net Income | -114.57% | -107.60% | -106.85% | -77.39% | -80.18% |
| EBIT | -35.32% | -32.25% | -10.41% | -21.42% | -10.90% |
| EBITDA | -18.64% | -15.99% | 0.93% | -4.59% | 4.70% |
| EPS Basic | -145.56% | -119.43% | -107.47% | -78.25% | -80.86% |
| Normalized Basic EPS | -40.10% | -38.10% | -15.73% | -27.65% | -16.19% |
| EPS Diluted | -146.71% | -120.13% | -107.73% | -78.39% | -81.06% |
| Normalized Diluted EPS | -40.01% | -37.95% | -15.53% | -27.51% | -16.04% |
| Average Basic Shares Outstanding | 0.91% | 1.90% | 2.88% | 3.69% | 3.08% |
| Average Diluted Shares Outstanding | 0.79% | 1.67% | 2.62% | 3.47% | 2.90% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -10.82% | -15.33% | -12.17% | 3.54% | 4.27% |